1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. ALNYLAM PHARMACEUTICALS INC
Alnylam Pharmaceuticals Inc XNAS: ALNY
446.51 -5.82 (-1.29%)
827.6K
XNAS Volume

XNAS 29 Aug, 2025 5:30 PM (EDT)

Board Meeting
The board meeting for Alnylam Pharmaceuticals Inc is scheduled for today, for the purpose of Alnylam Webcast to Discuss Results from the KARDIA-3 Phase 2 Study of Zilebesiran See details

Alnylam Pharmaceuticals Inc - ALNY - stock price prediction, stock price target, analyst ratings from 32 analysts

Alnylam Pharmaceuticals Inc has a share price target of US$ 424, revenue growth forecast of 55.8%, and profit growth estimate of 145.6% for FY25, based on top 32 analyst calls.